These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9518688)

  • 41. Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro.
    Zakrocka I; Targowska-Duda KM; Wnorowski A; Kocki T; Jóźwiak K; Turski WA
    Neurotox Res; 2019 Jan; 35(1):244-254. PubMed ID: 30178287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast.
    Cosi C; Mannaioni G; Cozzi A; Carlà V; Sili M; Cavone L; Maratea D; Moroni F
    Neuropharmacology; 2011 Jun; 60(7-8):1227-31. PubMed ID: 21110987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endogenous neuro-protectants in ammonia toxicity in the central nervous system: facts and hypotheses.
    Albrecht J; Wegrzynowicz M
    Metab Brain Dis; 2005 Dec; 20(4):253-63. PubMed ID: 16382336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.
    Beggiato S; Tanganelli S; Fuxe K; Antonelli T; Schwarcz R; Ferraro L
    Neuropharmacology; 2014 Jul; 82():11-8. PubMed ID: 24607890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of methionine sulfoximine on the glutamine and glutamate content and cell volume in rat cerebral cortical slices: involvement of mechanisms not related to inhibition of glutamine synthesis.
    Zielińska M; Stafiej A; Law RO; Albrecht J
    Neurotoxicology; 2004 Mar; 25(3):443-9. PubMed ID: 15019307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic d-amphetamine administration causes a reduction of kynurenic acid levels in rat brain.
    Rassoulpour A; Wu HQ; Poeggeler B; Schwarcz R
    Brain Res; 1998 Aug; 802(1-2):111-8. PubMed ID: 9748528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum.
    Okuno A; Fukuwatari T; Shibata K
    J Neurochem; 2011 Sep; 118(5):796-805. PubMed ID: 21711351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analog of kynurenic acid decreases tau pathology by modulating astrogliosis in rat model for tauopathy.
    Majerova P; Olesova D; Golisova G; Buralova M; Michalicova A; Vegh J; Piestansky J; Bhide M; Hanes J; Kovac A
    Biomed Pharmacother; 2022 Aug; 152():113257. PubMed ID: 35714514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Age-related changes in kynurenic acid production in rat brain.
    Gramsbergen JB; Schmidt W; Turski WA; Schwarcz R
    Brain Res; 1992 Aug; 588(1):1-5. PubMed ID: 1393560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endothelium-dependent production and liberation of kynurenic acid by rat aortic rings exposed to L-kynurenine.
    Stazka J; Luchowski P; Wielosz M; Kleinrok Z; Urbańska EM
    Eur J Pharmacol; 2002 Jul; 448(2-3):133-7. PubMed ID: 12144932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding.
    Chess AC; Bucci DJ
    Behav Brain Res; 2006 Jun; 170(2):326-32. PubMed ID: 16621049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kynurenic acid synthesis in bovine retinal slices--effect of glutamate agonists.
    Zarnowski T; Bialek M; Rejdak R; Zrenner E; Junemann A; Zagorski Z; Kocki T; Turski WA
    J Neural Transm (Vienna); 2006 Oct; 113(10):1367-72. PubMed ID: 16465462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection.
    Stone TW
    Trends Pharmacol Sci; 2000 Apr; 21(4):149-54. PubMed ID: 10740291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Memantine increases brain production of kynurenic acid via protein kinase A-dependent mechanism.
    Kloc R; Luchowska E; Wielosz M; Owe-Larsson B; Urbanska EM
    Neurosci Lett; 2008 Apr; 435(2):169-73. PubMed ID: 18346850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
    Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
    Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro.
    Di Serio C; Cozzi A; Angeli I; Doria L; Micucci I; Pellerito S; Mirone P; Masotti G; Moroni F; Tarantini F
    Cell Mol Neurobiol; 2005 Sep; 25(6):981-93. PubMed ID: 16392031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute Kynurenine Challenge Disrupts Sleep-Wake Architecture and Impairs Contextual Memory in Adult Rats.
    Pocivavsek A; Baratta AM; Mong JA; Viechweg SS
    Sleep; 2017 Nov; 40(11):. PubMed ID: 29029302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kynurenic Acid Induces Impairment of Oligodendrocyte Viability: On the Role of Glutamatergic Mechanisms.
    Langner E; Lemieszek MK; Kwiecień JM; Rajtar G; Rzeski W; Turski WA
    Neurochem Res; 2017 Mar; 42(3):838-845. PubMed ID: 27444613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.